Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening

Canadian Journal of Gastroenterology

Volumn 26, Issue 3, 2012, Pages 131-147

  Rabeneck, Linda ^a   Rumble, R Bryan ^b   Thompson, Frank ^c   Mills, Michael ^c   Oleschuk, Curtis ^d   Whibley, Alexandra ^c   Messersmith, Hans ^b   Lewis, Nancy ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c CANCER CARE ONTARIO   (Canada)

^d Diagnostic Services of Manitoba Inc   (Canada)

Author keywords

Cancer care ontario; Colorectal cancer screening; Fecal immunochemical tests; Guaiac fecal occult blood test

Indexed keywords

HEMOGLOBIN;

ARTICLE; CANADA; CANCER DIAGNOSIS; CANCER SCREENING; COLORECTAL CANCER; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; HEALTH PROGRAM; HUMAN; INTERMETHOD COMPARISON; OCCULT BLOOD TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; SYSTEMATIC REVIEW;

EID: 84858271005     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/486328     Document Type: Article

References (30)

1. Canadian Cancer Society's Steering Committee on Cancer Statistics. Canadian Cancer Statistics 2011. Toronto, Ontario, 2011. 〈www.cancer.ca/ canada-wide/about%20cancer/cancer%20statistics.aspx〉 (Accessed May 2011).
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
3. Canadian Task Force on Preventive Health Care. Colorectal cancer screening: Recommendation statement from the Canadian Task Force on preventive health care. CMAJ 2001;165:206-8.
4. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7. (Pubitemid 26400242)
5. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecaloccult- blood test. Lancet 1996;348:1467-71. (Pubitemid 26400241)
6. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71. (Pubitemid 23131388)
7. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial. Lancet 2010;375:1624-33.
8. Rabeneck L, Rumble RB, Axler J, et al. Cancer Care Ontario Colonoscopy Standards: Standards and evidentiary base. Can J Gastroenterol 2007;21(Suppl D):5D-24D. (Pubitemid 351247730)
9. Rabeneck L, Zwaal C, Goodman JH, Mai V, Zamkanei M. Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: Evidentiary base and recommendations. Clin Biochem 2008;41:1289-305.
10. Young GP, Cole S. New stool screening tests for colorectal cancer. Digestion 2007;76:26-33. (Pubitemid 47608857)
11. Young GP, St. John DJB. Faecal occult blood tests: Choice, usage and clinical applications. Clin Biochem Rev 1992;13:161-7.
12. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.
13. Mujoomdar M, Cimon K, Spry C. Fecal immunochemical tests for colorectal cancer screening: A systematic review of accuracy and compliance. Ottawa: Canadian Agency for Drugs and Technologies in Health, 2009:1-13.
14. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: A targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:638-58.
15. Hoffman RM, Steel S, Yee EF, Massie L, Schrader RM, Murata GH. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: A randomized, controlled trial. Prev Med 2010;50:297-9.
16. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: Randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59:62-8.
17. Hol L, Wilschut JA, Van Ballegooijen M, et al. Screening for colorectal cancer: Random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009;100:1103-10.
18. van Rossum LG, van Rijn AF, Laheij RJ, et al. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer 2009;101:1274-81.
19. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90. (Pubitemid 351899018)
20. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: Update on performance characteristics. J Natl Cancer Inst 2007;99:1462-70.
21. Grazzini G, Ventura L, Zappa M, et al. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: Observational study from the Florence district. Gut 2010;59:1511-5.
22. Grazzini G, Visioli CB, Zorzi M, et al. Immunochemical faecal occult blood test: Number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 2009;100:259-65.
23. Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010;105:2017-25.
24. Lamph SA, Bennitt WE, Brannon CR, Halloran SP. Evaluation Report: Immunochemical Faecal Occult Blood Tests. Guildford: Centre for evidence-based purchasing 2009:4-40.
25. Halloran SP, Launoy G, Zappa M. Faecal occult blood testing In: Segnan N, Patnick J, von Karsa L, eds. European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis, 1st edn. Luxembourg: Publications Office of the European Union; 2010:103-44.
26. Health Council of the Netherlands. A national colorectal cancer screening programme. The Hague: Health Council of the Netherlands; 2009; publication no. 2009/13E.
27. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95. (Pubitemid 351615355)
28. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 2009;104:739-50.
29. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996;334:155-9. (Pubitemid 26017953)
30. St John DJ, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993;104:1661-8. (Pubitemid 23235456)